Interleukin-lbeta

Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S (1999) Interleukin-lbeta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25 255-259... 

Newton, R. et al. Superinduction of COX-2 mRNA by cycloheximide and interleukin-lbeta involves increased transcription and correlates with increased NF-kappaB and JNK activation. FEBS Lett. 418, 135, 1997. 

Parsadaniantz, S. M. et al. Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxy-genase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-lbeta in the male Rat. J. Neuroendocrinol. 12, 766, 2000. 

Denis, F. and Archambault, D., Molecular cloning and characterization of beluga whale (Delphinapterus leucas) interleukin-lbeta and timour necorsis factor-alpha, Can. J. Vet. Res., 65, 233, 2001. 

Nikolova-Karakashian, M., Morgan, E.T., Alexander, C., Liotta, D.C., Merrill, A.H.Jr., 1997, Bimodal regulation of ceramidase by interleukin-lbeta. Implications for the regulation of cytochrome P450 2C11. J. Biol. Chem. 272 18718-18724. 

Ito, K., Barnes, P.J. and Adcock, I.M. (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-lbeta-induced histone H4 acetylation on lysines 8 and 12. Molecular and Cellular Biology, 20, 6891-6903. 

Sahni, A., Guo, M., Sahni, S. K., and Francis, C. W. (2004). Interleukin-lbeta but not IL-lalpha binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood 104, 409-414. 

Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y et al. Lack of interleukin-lbeta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vase Biol 2003, 23(4) 656-660. 

Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R et al. Polymorphisms of the interleukin-lbeta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vase Biol 2005, 25(l) 222-227. 

Ye, J. and Laychock, S. G. (1998). A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-lbeta. Endocrinology 139, 4155-4163. 

Dello Russo C, Boulleme AI, Gavrilyuk V, Feinstein DL (2004) Inhibition of microglial inflammatory responses by norepinephrine effects on nitric oxide and interleukin-lbeta production../, Neuroinflammation 1 9. 

Sung, C. S, Wen, Z. H., Chang, W. K., Ho, S. T., Tsai, S. K., Chang, Y. C., and Wong, C. S. (2004). Intrathecal interleukin-lbeta administration induces themal hyperalgesia by activating indudble nitric oxide synthase expression in the rat spinal cord. Brain Res. 1051, 145—153. 

Liu,J. S., John, G. R., Sikora, A., Lee, S. C., and Brosnan, C. F. (2000). Modulation of interleukin-lbeta and tumor necrosis factor alpha signaling by P2 purinergic receptors in human fetal astrocytes. J. Neurosci. 20, 5292-5299. 

Salter DM, Wallace WH, Robb JE, Caldwel H, Wright MO. Human bone cell hyperpolarization response to cyclical mechanical strain is mediated by an interleukin-lbeta autocrine/paracrine loop. J Bone Miner Res. 2000 15 1746-1755. 

Interleukin-lbeta is present in culture media of embryos, and the level correlates significantly with pregnancy (B3). 

Deage, V., Burger, D., Dayee, J. M. (1998). Exposure of T lymphocytes to Lefluno-mide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-lbeta and metalloproteinases. Eur. Cytokine Netu>. 

Fas assodated death domain (FADD)-like interleukin-lbeta-converting enzyme inhibitory proteins (FLIP) Engidawork et al. 2001c... 

Nishimura M, Mizuta I, Mizuta E, Yamasaki S, Ohta M, Kuno S (2000) Influence of interleukin-lbeta gene polymorphisms on age-at-onset of sporadic Parkinson s disease. Neurosci Lett 284 73-76. 

Furse, R.K., Rossetti, R.G., Seiler, C.M., and Zurier, R.B. 2002. Oral administration of gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-lbeta production by human monocytes. J. Clin. Immunol. 22, 83-91. 

Assenat, E., Gerbal-Chaloin, S., Larrey, D., Saric, J., Fabre, J. M., Maurel, P., Vilarem, M. J., and Pascussi, J. M. (2004) Interleukin lbeta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40, 951-960. 

Schmid B, Wong S, Mitchell BF Transcriptional regulation of oxytocin receptor by interleukin-lbeta... 

Kaneyama K, Segami N, Sun W, et al. (2005). Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-lbeta, soluble tumor necrosis factor receptors I and II,... 

Takeuchi R, Tsutsumi H, Osaki M et al. Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-lbeta-converting enzyme gene expression but does not cause apoptosis. J Virol 1998 72(5) 4498-502. 

Takahashi, K., Goomer, R.S., Harwood, F., Kubo, T., Hirasawa, Y., Amiel, D. 1999. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-lbeta(lL-lbeta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthr. Cartil 7(2), 182-190. 

Sachs, D., CoeUio, F. M., Costa, V. V., Lopes, F., Pinho, V., Amaral, F. A., et al. (2011). Cooperative role of tumour necrosis factor-alpha, interleukin-lbeta and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypemociception in mice. British Journcd of Phatnuicolagy, 162(1), 72—83. 

Messud Petit F, Gdfi J, Delverdier M et al. Setp-2, an inhibitor of the interleukin-lbeta-converting enzyme, is critical in the pathophysiology of myxoma virus. J Virol 1998 72 7830-7839. 

Lizard, G., S. Lemaire, S. Monier, S. Gueldry, D. Neel, and P. Gambert. 1997. Induction of apoptosis and of interleukin-lbeta secretion by 7beta-hydroxycholesterol and 7-keto-cholesterol Partial inhibition by Bcl-2 overexpression. 419 (2-3) 276-80. 

---